AXA Venture Partners

AXA Venture Partners (formerly known as AXA Strategic Ventures) is a $425 million venture capital fund. Its target sectors are enterprise software, Fintech/Insurtech, consumer technologies and digital health. Its checks range from $300k to $20m. The CVC's relationship with AXA also provides access to over 107m customers across 64 countries.

Launched in 2015, the original fund is dedicated to investing AXA Group money in budding strategic innovations in the insurance, asset management, financial technology and healthcare service industries.

In 2019 AXA Venture Partners launched a second, Late Growth Fund, worth €250m. External investors are set to join the fund, with an aim of increasing the fund's value to €1bn.

AXA Venture Partners portfolio includes Goji, Limelight Health, Neura, Wellth and One inc.

Led by François Robinet (Managing Partners), AXA Venture Partners has offices in Paris, San Francisco, New York and London.

In April 2021 AXA Venture Partners announced the €250m first closing for AVP Growth Fund II, with the company planning to double the fund by the end of 2021. The new fund will invest from early to late growth, and is dedicated to support 'future technology leaders'. 

In May 2023 AXA Venture Partners announced a €1.5bn late-stage fund to invest in European and North American tech startups. It will target companies that are expected to go public within the next three to four years. French insurance company AXA SA was the biggest investor, putting in €750m. It will keep AVP’s current focus on software, fintech, insurtech, digital health and consumer technologies.